Purpose: This study evaluated the quality of DNA obtained from stored human saliva and its applicability to human identification.
Introduction
Human identification is one of the most significant areas of study within Forensic Dentistry and Medicine. Both fields use the human body, in life or in various stages of postmortem (sliced, dilacerated, charred, macerated, decayed, in the process of skeletonization or already skeletonized), to establish human identification, which is essential for human relations, both at social and judicial levels (1). Identification techniques using DNA have already been established as a robust process, with a high power of distinction and high reliability, accepted as legal proof in judicial cases such as paternity inclusion and exclusion and human identification (2). One of the main advantages of DNA use in forensic sciences lies in the fact that it can be extracted from different sources, such as blood samples, saliva, mouth mucosa cells (on cigarettes, envelopes, etc.), bone, teeth, tissues, organs, hair strands, semen, urine, feces, sweat, prints and other biological materials (3). In most cases of genetic studies of families and populations, DNA is still obtained from blood. However, according to some authors (4, 5) , the use of saliva and mouth swabs as sources of DNA shows some technical advantages over the use of blood. Collection is easier and painless, especially considering that it can be done on babies, children and elderly subjects, and does not have the religious implications of using blood. Also, there are higher potential risks of contamination when using blood, especially from hepatitis and AIDS, due to the use of sharp objects such as needles (5). Forensic studies have demonstrated that DNA analysis using the PCR of saliva deposited in prints, bite marks, cigarette butts, marks and prints left on stamps and other objects may help in individual identification (6-9). The objective of this work was to evaluate the quality of DNA obtained from human saliva stored for two different periods, 7 and 180 days, and its applicability to the identification of individuals in forensic dentistry.
Methodology
This research was approved by the Research Ethics Committee of the Bauru School of Dentistry (no. 140/200) in accordance with the Brazilian Resolution 196/96 (10). The saliva sample was collected from patients and staff of both genders and various ages at the Bauru School of Dentistry (FOB-USP). Saliva was collected after informed consent forms were filled out. A total of 40 saliva samples were collected from 20 subjects, with each participant contributing two samples, one from saliva in natura and another using the single mouth swab technique.
Saliva collection
Saliva samples were collected using a sterile swab applied to the internal mouth mucosa and dried in a ventilated environment in the shade. Two milliliters of saliva in natura was collected without previous salivary stimulation but discarding the first saliva collection. These samples were stored in plastic microcentrifuge tubes and kept at -20 o C.
First Stage -7 days

DNA Extraction
During this stage, in natura and swab saliva samples were analyzed. DNA extraction from saliva was conducted based on the technique documented by Umeda (11) , modified by Sakai et al. (12) , using InstaGene Matrix resin (Bio-Rad Laboratories Inc., Hercules, CA, USA).
PCR reactions for the B-actin gene
For the PCR reaction, the study used the B-actin gene, whose amplified product is 351 base pairs (bp). This gene was chosen because it is exclusively human and frequently used in research. For the reaction, a mixture was prepared containing 5 µL of DNA sample from saliva or swab, 5 µL of PCR buffer (Gibco/BRL, Life Technologies, Inc., Gaithersburg, MD, USA), 1.25 units of Taq DNA Polymerase (Taq Promega ® , Promega Corporation, USA), 0.2 mM deoxynucleotides (Invitrogen, USA), 0.4 µM primer, and 1.5 mM magnesium chloride (Gibco/BRL). The primer sequence used to amplify the B-actin gene is shown in Table 1 . As a positive control, human DNA was used from blood collected from one of the researchers after filling out the informed consent form; for a negative control, water was used. The DNA concentration in the blood sample used as positive control was 220 µg/mL. The samples were handled using gloves and masks in a sterile environment and for very brief periods at a time. The deionized water used in the PCR reactions was autoclaved, as were the other solutions, with the exception of the starters, dNTPs, buffer, and Taq DNA polymerase. In addition, the PCR reagents were mixed in a single tube and later added to the microcentrifuge tubes containing the individual DNA samples. The thermal cycling conditions used for this pair of primers were as follows: 94ºC for 2 min, 40 cycles of 94ºC for 45 s, 58ºC for 30s, and 72ºC for 1.5 min, followed by a final period at 72ºC for 10 min.
Electrophoresis and PCR production detection
PCR products (10 µL from each amplified sample) were analyzed using horizontal electrophoresis in 2% agarose gel with a 100 V current for 1 hour. After electrophoresis, the agarose gel was photographed to record the presence of amplified products of anticipated sizes. The molecular weight of the PCR products was determined by comparison to a 100 bp molecular weight marker (Amersham Pharmacia Biotech, England).
Second Stage -180 days
Only the n=20 saliva samples collected by mouth swab were analyzed because the results of the first stage did not show differences between the two collection methods and also because saliva collection using mouth swabs is more practical. The DNA extraction method was the same as that used in the first stage, as were the reagents and PCR conditions for the B-actin gene.
PCR reaction for the SIX3-2 gene
In order to perfect the proposed analysis and due to the detection of a trace of agarose gel in the amplification of the human B-actin gene (a strong indicator that the extracted DNA could be of insufficient quality for forensic analysis), another human gene, SIX3-2, was used. Thus, it was possible to evaluate whether the problem was in the quality of the extracted DNA or in the amplification of the gene. Additionally, to test the same DNA after the PCR, the MbO1 restriction enzyme was used to analyze a polymorphism in the ADRA-2A gene.
The amplification of the SIX3-2 gene was performed in only 14 mouth swab saliva samples because the objective was only to verify the quality of extracted DNA. The DNA samples were quantified using a GE ® spectrophotometer (General Electric, USA) and diluted to a final concentration of 20 ng/mL. The amplification of SIX3-2 was performed in a 20 µL volume containing genomic DNA (60 ng, 2.0 µL), dNTPs (100 µM, 0.3 µL), primers (25 pmol each, 0.4 µL each) and Taq polymerase (5 U, 0.3 µL). The PCR Enhancer Kit (Invitrogen, Canada), consisting of 10X buffer (2.0 µL), MgSO4 (0.6 µL) and enhancer solution (1.0 µL), was used in the reactions. The sequences of primers used in the amplification of gene SIX3-2 can be found in Table 1 . The thermal cycling conditions used for this pair of primers were as follows: 94ºC for 4 min, 40 cycles of 94ºC for 30 s, 56ºC for 30 s, 72ºC for 1.0 min, followed by a final period of 72ºC for 7 min. Electrophoresis was conducted as described above, with an amplified product of 374 bp.
Digestion using Mb01 restriction enzyme for analysis of an ADRA-2A gene polymorphism
Because the objective of this procedure was to analyze the quality of the DNA obtained in analyses after PCR, only 8 samples were subjected to digestion for 2 h using the MbO1 restriction enzyme. Samples 1, 2, 5, 6, 8, 10, 12 and 14 were selected. The reagents used were PCR product (15.0 µL), H2O (5.5 µL), enzyme buffer (2.5 µL), restriction enzyme (2.0 µL), and oil (1 drop) at 37ºC. Digestion with the MbO1 enzyme resulted in four constant fragments (5, 62, 116 and 165 bp). The sequences of primers used for PCR before the digestion of the ADRA-2A gene are displayed in Table 1 .
Statistical Analysis
Data were analyzed with the McNemar test at a 5% significance level using the SAS software 9.1 (SAS Institute Inc., Cary, NC, USA).
Results
First stage -7 days (Table 2) All in natura and mouth swab saliva samples were subjected to DNA extraction and PCR, and DNA extraction and PCR were achieved in 97.5% of the samples (Table 3 ). There were no statistically significant differences found between the types of saliva collection (P=0.289). Also, there was no concurrence between the responses for samples from the same individual, i.e., when the response was negative for one type of sample (saliva in natura or from mouth swab), it was positive for the other from the same individual. Second Stage -180 days (Table 4) 
B-actin gene amplification
The amplification of the B-actin gene was possible in all 20 (100%) samples of saliva collected via mouth swab analyzed after 180 days of storage ( Fig. 1 and 2 ).
SIX3-2 gene amplification
Of the 14 samples selected for SIX3-2 gene amplification, the results indicated a positive amplification for 12 samples (86%), which shows that the DNA has the quality required for molecular analysis (Fig. 3 and 4) .
Digestion with Mb01 restriction enzyme
The results showed that all selected samples (n=8) were successfully digested with the restriction enzyme, which confirms that the extracted DNA has the quality required for forensic analysis (Fig. 5) . . PCR pattern obtained in mouth swab saliva samples. 2% agarose gel stained with ethidium bromide. Column 1, molecular weight marker for 100 bp; columns 2-11, mouth swab saliva DNA samples (samples: 11, 12, 13, 14, 15, 16, 17, 18, 19, 20) . Fig. 3 . PCR pattern obtained for the amplification of gene SIX3-2. 2% agarose gel stained with ethidium bromide. Column 1, molecular weight marker for 100 bp; columns 2-6, samples of PCR products of mouth swab saliva (samples: 1, 2, 4, 5, 6). 2% agarose gel stained with ethidium bromide. Column 1, molecular weight marker for 100 bp; columns 2-10, samples of PCR products of mouth swab saliva (3, 7, 8, 9, 10, 11, 12, 14) .
Discussion
The biological material found at the crime scene or collected from cadavers and mortal remains, present either in the victim's body or on objects, often is scarce or degraded (13, 14) . There is concern regarding the preservation of biological samples for DNA extraction and analysis, and these procedures are specified in the existing rules (13-16). Contamination by external DNA was vigilantly avoided in this study because it would hinder or even make impossible the extraction of the relevant DNA, especially because the use of PCR techniques enables the amplification of even a single DNA molecule, however degraded it may be (17). This single molecule, by contaminating the biological samples, could compromise the analysis of the genetic profile and consequently make the individual's identification impossible.
If the contaminating DNA is present in comparable levels to the target DNA, its amplification could confuse the interpretation of the typing results. Whenever saliva is used as a source of DNA, such a risk of contamination by foreign DNA must be considered due to the ease of contact with other materials through the mouth. INTERPOL rules (14) cite that constant freezing and thawing of samples can degrade the DNA. Therefore, care was taken to store the mouth swabs containing saliva in two microcentrifuge tubes, so they could be frozen at -20ºC until use, each tube for a separate experimental stage. Controls were used to aid in the detection of contaminants.
In the case of the negative controls (water), the desired amplification did not occur; for the positive controls, the amplification was identical to that obtained with human saliva, indicating the absence of contamination and proving its condition as human DNA. Thus, it can be affirmed that human saliva is a reliable and alternative source for DNA extraction compared to blood as reported previously (4,5,18). Moreover, saliva-derived PCR is based on repeated rinsing and centrifuging (11). The main objectives of these measures are to remove possible PCR inhibitors, such as phenol, protease K, excess chelating agents, hemoglobin and other red blood cell proteins, and high salt concentrations, and to allow a reduction in the detection limit of target cells. This protocol was properly followed, with rinsing and centrifuging repeated four times, as per the instructions of the above-mentioned author.
Considering that saliva -a biological material -may contain PCR-inhibiting molecules, it became necessary to use a commercial DNA purification matrix, even after repeated rinsing and centrifuging, because inhibition would not be overcome by an increase in the amount of primers or in the amount of DNA in the PCR reaction. These increases would also introduce more inhibitors into the reaction. The matrix is able to chelate bivalent ions, favoring the efficiency of DNA extraction and protecting the DNA at high temperatures (19). Thus, the Chelex 100 (Bio-Rad Laboratories, Inc., Hercules, CA, USA) or InstaGene Matrix (Bio-Rad Laboratories, Inc., Hercules, CA, USA) resins could be used. However, studies on the use of Chelex 100 for DNA extraction resulted in weak and poorly visible bands for the sought targets (11, 12, 19) . As such, InstaGene Matrix was used according to the manufacturer's instructions, with positive results. Whenever the topic of biological material storage is discussed, specifically in this context of human saliva, there are questions regarding whether degradation of the material would occur over time. Previous studies showed that saliva could be stored without undergoing changes (4,18). Those works achieved very promising results with the use of saliva in molecular biology because specific products of the correct size were obtained for all samples, even under different less-than-ideal storage conditions. Some authors obtained the same band patterns for the same individuals from saliva stains in mouth gags, envelopes and swabs, fresh saliva, blood, saliva from bite marks and skin (20,21), saliva stains (6), fresh saliva or in natura (4,18) from stamps and letters (22) and from foods, such as cheese (9). This work evaluated the durability of saliva when stored for the periods of 7 and 180 days. The first period was defined according to the end of saliva collection, which totaled six days, and the second period (180 days) was established according to the literature (4,18) and the deadline for issuing the results. In the first stage of this research, human DNA extraction was possible in 97.5% of samples, whereas in the second stage, extraction was possible in 100% of cases. This supports the possibility of storing human saliva without the risk of changes to it or its DNA for at least 180 days prior to its use for genetic material extraction. This strengthens the conclusion that, if degradation of stored material occurs, it does not diminish the quality of the material for later molecular biology analyses. The results of the first stage of this study showed no statistically significant differences between the two methods of saliva collection. Furthermore, when detection of a target gene was not possible in a given sample, it was possible to amplify the target gene from the other sample of the same individual. In other words, when the expected band pattern was not obtained for a sample of saliva in natura, the pattern was observed in the mouth swab sample from the same individual, and vice versa. Therefore, for the second stage, it was decided only to repeat the DNA analysis reactions in saliva from mouth swabs, due to the fact that swab collection is easier compared to saliva in natura. The results of this second phase confirmed the possibility of using human saliva for identification because most samples responded positively, both in PCR reactions and in digestion with the MbO1 restriction enzyme. The use of different genes occurred due to questions regarding the quality of the DNA extracted from amplification of the B-actin gene because the gel showed a stain that could indicate a problem in the amplification or low quality of the extracted DNA, which was the focal issue of the study. Therefore, in addition to B-actin, the SIX3-2 gene was used as well for its proven track record in the lab, featuring a well defined application protocol, with the objective of analyzing the quality of the DNA for forensic comparison. With that same purpose, digestion using the Mb01 restriction enzyme was applied. The results indicated good qualitative use of the DNA extracted from human saliva in both analysis periods (7 and 180 days).
Conclusions
These results showed that the quantity and quality of DNA from saliva, even after a period in storage, and the techniques employed are adequate for forensic DNA analysis.
